Carphedon

Phenylpiracetam
Clinical data


Trade names	Phenotropil; Carphedon
Pregnancy category	Unknown
Routes of administration	Oral (tablets)
ATC code	None
Legal status
Legal status	Legal ℞-only (RU)
Pharmacokinetic data
Bioavailability	~100%
Metabolism	None
Biological half-life	3–5 hours
Excretion	Urine (~40%), bile and perspiration (~60%)
Identifiers
IUPAC name (R,S)-2-(2-oxo-4-phenylpyrrolidin-1-yl)acetamide
CAS Number	77472-70-9^Y
PubChem CID	132441
ChemSpider	116950^N
UNII	99QW5JU66Y
ECHA InfoCard	100.214.874
Chemical and physical data
Formula	C₁₂H₁₄N₂O₂
Molar mass	218.3 g/mol
3D model (Jmol)	Interactive image
Chirality	Racemic mixture
Boiling point	486.4 °C (907.5 °F)
SMILES C1=CC=CC=C1C2CN(C(C2)=O)CC(=O)N
InChI InChI=1S/C12H14N2O2/c13-11(15)8-14-7-10(6-12(14)16)9-4-2-1-3-5-9/h1-5,10H,6-8H2,(H2,13,15)^N Key:LYONXVJRBWWGQO-UHFFFAOYSA-N^N
^NY (what is this?)

Phenylpiracetam (INN: fonturacetam, brand names Phenotropil, Carphedon), also called is a phenylated analog of the drug piracetam which was developed in 1983 in Russia where it is available as a prescription drug. Research on animals has indicated that phenylpiracetam may have anti-amnesic, antidepressant, anticonvulsant, antipsychotic, anxiolytic, and memory enhancement effects.

A few small clinical studies have shown possible links between prescription of phenylpiracetam and improvement in a number of encephalopathic conditions, including lesions of cerebral blood pathways, traumatic brain injury and certain types of glioma.

Phenylpiracetam reverses the depressant effects of the benzodiazepine diazepam, increases operant behavior, inhibits post-rotational nystagmus, prevents retrograde amnesia, and has anticonvulsant properties.

Phenylpiracetam is typically prescribed as a general stimulant or to increase tolerance to extreme temperatures and stress.